皇家华人

The plans will transform the site at 256 Gray鈥檚 Inn Road, London, bringing together research scientists, clinicians and patients to create a world-leading hub for dementia and neurological disease research. 听

UCL is a global leader in pioneering research into neurological diseases such as Alzheimer鈥檚 disease, multiple sclerosis, Huntington鈥檚 disease, n别耻谤辞尘耻蝉肠耻濒补谤听诲颈蝉别补蝉别蝉,听Parkinson鈥檚 disease, motor neurone disease, stroke and epilepsy. The new facility will create a collaborative, interdisciplinary environment to translate UCL鈥檚 research power into developing treatments for these conditions.

The site, which currently comprises the Eastman Dental Hospital, the former Royal Free Hospital, the UCL Eastman Dental Clinic and the Levy Wing, is part of a major redevelopment project and will house over 500 neurological research scientists from UCL Queen Square Institute of Neurology and the UK Dementia Research Institute (UK DRI), along with the UK DRI national headquarters. The building will also house outpatient consulting and an MRI suite for the UCLH National Hospital for Neurology and Neurosurgery.

MediaCentral Widget Placeholder

Professor Alan Thompson, Dean of UCL Faculty of Brain Sciences and Garfield Weston Professor of Clinical Neurology and Neurorehabilitation, said: 鈥淲e are delighted Camden Council has approved these plans, which will ensure this historic site remains at the heart of London鈥檚 cutting-edge health and science communities.

鈥淭his world-leading facility will transform our ability to tackle the devastating global health challenge of neurological diseases such as dementia, which is now the leading cause of death in England and Wales.

鈥淏y bringing the new building into UCL鈥檚 existing neuroscience community, we aim to create the most comprehensive, coordinated translational neuroscience research hub in the world.鈥�

The new facility, part of the Transforming UCL programme, is due to be completed in 2024 and will offer benefits that extend beyond its four walls. Shared laboratory space, services and equipment will support collaboration across the whole of UCL鈥檚 neuroscience community, accelerating the discovery of new treatments. The focus on shared facilities will also encourage efficiency and sustainability. All of the building鈥檚 laboratories are designed to be reconfigurable so they can adapt to evolving research techniques and support future generations in developing breakthrough treatments.

Respect for the environment and local community are key principles underpinning the development. The new building will target BREEAM Excellent rating, aiming to reduce carbon emissions by 40% and produce low levels of waste going into landfill from the construction process. It will be open to the public with a caf茅 and exhibition spaces as well as thoroughfares for both walkers and cyclists. New landscaped areas will include a sensory garden, a courtyard and plenty of green space to create a calm environment for patients, visitors, workers and residents alike.

The new building will cost 拢281.6m听and will be听funded from a combination of UCL, public and philanthropic sources.

Notes

• Camden Council granted planning permission, subject to a Section 106 Agreement,听at a meeting on Thursday 19^th September 2019.听
• The Eastman Dental Hospital site will be vacated in late 2019.

Links

• UCL Brain Sciences
• UCL Queen Square Institute of Neurology

Media contact听

Henry Killworth

Tel: +44 (0) 0207 679 5296

E: h.killworth [at] ucl.ac.uk

听

听

听